Good Start Genetics Announces Expansion of VeriYou

Good Start Genetics, a leading family genomics company, announces the expansion of VeriYou, the company’s physician-ordered, genetic counseling-supported, at-home carrier screening test, to now include 19 inherited genetic disorders more prevalent in the Ashkenazi Jewish population.

Good Start Genetics is dedicated to women’s health and helping grow healthy families through its best-in-class genetics offerings. Using advanced clinical sequencing, proprietary methods, and information tailored to the individual, the Company’s suite of offerings arms clinicians and patients with insightful and actionable information to promote successful pregnancies and help build healthy families.

The National Jewish Genetic Consortium and medical guidelines for recommend screening for these disorders among those of Ashkenazi Jewish descent. Good Start Genetics is the first company to bring clinical-grade, physician ordered and affordable carrier screening tests into the home, accompanied by access to board-certified genetic counselors. According to the National Institutes of Health (NIH), nearly one in five people of Ashkenazi Jewish descent are carriers of a Jewish genetic disorder.

In November of 2016, Good Start Genetics announced its partnership with Amazon as the first genetic testing company with a direct relationship with the online retailer. In addition to the flagship VeriYou CF/SMA test, which offers testing for cystic fibrosis and spinal muscular atrophy, the newest addition, the VeriYou AJ/SMA test, offering testing for the spinal muscular atrophy and the 17 most prevalent genetic disorders in the Ashkenazi Jewish population, will also be available for purchase on or direct at

The VeriYou AJ/SMA test includes screening for cystic fibrosis and spinal muscular atrophy, the two most common genetic disorders in the U.S., and the 17 additional genetic disorders most common in the Ashkenazi Jewish population, including Bloom’s Syndrome, Canavan disease, dihydrolipoamide dehydrogenase deficiency, familiar dysautonomia, familiar hyperinsulinism, Fanconi anemia (group C), Gaucher disease, glycogyn storage disease type 1a, Joubert syndrome 2, maple syrup urine disease 1A/1B, mucolipidosis type IV, Nemaline myopathy, Neimann-Pick disease type A/B, Tay-Sachs disease, Usher syndrome type III, Usher syndrome type IF, and Walker-Warburg syndrome.

Good Start Genetics product portfolio, including GeneVu, EmbryVu, and VeriYou, encompass a multifaceted approach to genetic testing, featuring solutions for both preimplantation and carrier screening, while offering comprehensive and flexible testing options helping a wider range of couples find their paths to pregnancy at significantly lower costs.

Related Articles at

* FDA Approves 23AndMe’s Test for Bloom Syndrome

* Neimann-Pick Type C is a Rare Genetic Disease

* Good Start Genetics Offers Carrier Screening

< Return To Blog

Leave a Reply

Your email address will not be published.